DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.
Accurate duplication of DNA prior to cell division is essential to suppress mutagenesis and tumour development. The high fidelity of eukaryotic DNA replication is due to a combination of accurate incorporation of nucleotides into the nascent DNA strand by DNA polymerases, the recognition and removal...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2013
|
| _version_ | 1797090083190341632 |
|---|---|
| author | Church, D Briggs, SE Palles, C Domingo, E Kearsey, S Grimes, J Gorman, M Martin, L Howarth, K Hodgson, S NSECG Collaborators Kaur, K Taylor, J Tomlinson, I |
| author_facet | Church, D Briggs, SE Palles, C Domingo, E Kearsey, S Grimes, J Gorman, M Martin, L Howarth, K Hodgson, S NSECG Collaborators Kaur, K Taylor, J Tomlinson, I |
| author_sort | Church, D |
| collection | OXFORD |
| description | Accurate duplication of DNA prior to cell division is essential to suppress mutagenesis and tumour development. The high fidelity of eukaryotic DNA replication is due to a combination of accurate incorporation of nucleotides into the nascent DNA strand by DNA polymerases, the recognition and removal of mispaired nucleotides (proofreading) by the exonuclease activity of DNA polymerases δ and ε, and post-replication surveillance and repair of newly synthesized DNA by the mismatch repair (MMR) apparatus. While the contribution of defective MMR to neoplasia is well recognized, evidence that faulty DNA polymerase activity is important in cancer development has been limited. We have recently shown that germline POLE and POLD1 exonuclease domain mutations (EDMs) predispose to colorectal cancer (CRC) and, in the latter case, to endometrial cancer (EC). Somatic POLE mutations also occur in 5-10% of sporadic CRCs and underlie a hypermutator, microsatellite-stable molecular phenotype. We hypothesized that sporadic ECs might also acquire somatic POLE and/or POLD1 mutations. Here, we have found that missense POLE EDMs with good evidence of pathogenic effects are present in 7% of a set of 173 endometrial cancers, although POLD1 EDMs are uncommon. The POLE mutations localized to highly conserved residues and were strongly predicted to affect proofreading. Consistent with this, POLE-mutant tumours were hypermutated, with a high frequency of base substitutions, and an especially large relative excess of G:C>T:A transversions. All POLE EDM tumours were microsatellite stable, suggesting that defects in either DNA proofreading or MMR provide alternative mechanisms to achieve genomic instability and tumourigenesis. |
| first_indexed | 2024-03-07T03:13:23Z |
| format | Journal article |
| id | oxford-uuid:b4fb97cf-15b0-44da-8409-8914e789d79f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:13:23Z |
| publishDate | 2013 |
| record_format | dspace |
| spelling | oxford-uuid:b4fb97cf-15b0-44da-8409-8914e789d79f2022-03-27T04:30:02ZDNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b4fb97cf-15b0-44da-8409-8914e789d79fEnglishSymplectic Elements at Oxford2013Church, DBriggs, SEPalles, CDomingo, EKearsey, SGrimes, JGorman, MMartin, LHowarth, KHodgson, SNSECG CollaboratorsKaur, KTaylor, JTomlinson, IAccurate duplication of DNA prior to cell division is essential to suppress mutagenesis and tumour development. The high fidelity of eukaryotic DNA replication is due to a combination of accurate incorporation of nucleotides into the nascent DNA strand by DNA polymerases, the recognition and removal of mispaired nucleotides (proofreading) by the exonuclease activity of DNA polymerases δ and ε, and post-replication surveillance and repair of newly synthesized DNA by the mismatch repair (MMR) apparatus. While the contribution of defective MMR to neoplasia is well recognized, evidence that faulty DNA polymerase activity is important in cancer development has been limited. We have recently shown that germline POLE and POLD1 exonuclease domain mutations (EDMs) predispose to colorectal cancer (CRC) and, in the latter case, to endometrial cancer (EC). Somatic POLE mutations also occur in 5-10% of sporadic CRCs and underlie a hypermutator, microsatellite-stable molecular phenotype. We hypothesized that sporadic ECs might also acquire somatic POLE and/or POLD1 mutations. Here, we have found that missense POLE EDMs with good evidence of pathogenic effects are present in 7% of a set of 173 endometrial cancers, although POLD1 EDMs are uncommon. The POLE mutations localized to highly conserved residues and were strongly predicted to affect proofreading. Consistent with this, POLE-mutant tumours were hypermutated, with a high frequency of base substitutions, and an especially large relative excess of G:C>T:A transversions. All POLE EDM tumours were microsatellite stable, suggesting that defects in either DNA proofreading or MMR provide alternative mechanisms to achieve genomic instability and tumourigenesis. |
| spellingShingle | Church, D Briggs, SE Palles, C Domingo, E Kearsey, S Grimes, J Gorman, M Martin, L Howarth, K Hodgson, S NSECG Collaborators Kaur, K Taylor, J Tomlinson, I DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. |
| title | DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. |
| title_full | DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. |
| title_fullStr | DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. |
| title_full_unstemmed | DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. |
| title_short | DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. |
| title_sort | dna polymerase ε and δ exonuclease domain mutations in endometrial cancer |
| work_keys_str_mv | AT churchd dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT briggsse dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT pallesc dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT domingoe dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT kearseys dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT grimesj dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT gormanm dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT martinl dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT howarthk dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT hodgsons dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT nsecgcollaborators dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT kaurk dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT taylorj dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer AT tomlinsoni dnapolymeraseeanddexonucleasedomainmutationsinendometrialcancer |